These recommendations will be subject to change upon formal regulatory approval and the publication of licensed prescribing guidance
The extended half-lives of weekly formulations mean these medications do accumulate to some degree with repeated dosing until reaching what is termed 'steady state'a predictable, stable concentration that optimises therapeutic benefit whilst minimising adverse effects
International Journal of Obesity , 33(9), 956961
Injection technique and sites Semaglutide with glycine is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm
Diabetes Care 48 (7), 10571082
In vivo, GLP-1 is a substrate for DPP-4 and is rapidly metabolized to GLP-1 (937) or GLP-1 (936) NH 2 1